Time, Cost, and Efficacy Study of Identifying Group A Streptococci with Commercially Available Reagents

AUTOR(ES)

Chitwood, Lawrence A.

RESUMO

During the 12-month period primary throat, wound, and skin cultures, tentatively identified as B streptococci, were submitted by 10 different clinical laboratories for evaluation. A total of 692 beta-hemolytic streptococci were isolated from cultures submitted and examined in parallel by the fluorescent-antibody, precipitin, and bacitracin techniques. An evaluation of the specificity and sensitivity in conjunction with basic and personnel costs was determined for each method. The standard Lancefield precipitin method was established as the standard by which the bacitracin and flourescent antibody techniques were compared. With some variation depending on the commerical source of the disc, approximately 7% of the strains examined produced false reactions with the bacitracin disc. False-negative reactions were rarely noted by the group A fluorescent antibody technique (0.5%), but an appreciable number of other Lancefield groups (B, C, and G) were nonreactive with homologous conjugates.

Documentos Relacionados

• Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings.
• Effect of Transport Time, Temperature, and Concentration on the Survival of Group B Streptococci in Amies Transport Medium
• Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture.
• Comparison of commercially available group B streptococcal latex agglutination assays.
• OVERWEIGHT, CAUSES, COST, AND CONTROL